This application contains a proposal to be awarded a Clinical Research Skills Development program and to be selected as a Core Clinical Center (CCC) for the Cardiothoracic Surgical Trials Network (CTSN). We describe our experience as one of the two Clinical Research Skills Development programs funded at the initiation of the CTSN and outline our proposed innovations to improve recruitment of trainees who have outstanding potential to become leaders in academic thoracic surgery in the field of clinical research. We also describe the proposed educational environment, mentorship, and access to support in completing a clinical research project to achieve a Master's level degree in clinical research. We also propose to be a high-performing CCC through superior recruitment and retention of cardiac surgical patients for clinical trials developed by the Network; we can achieve this by working together with other sites and the Data Coordinating Center to promote effective trial design and analysis and by contributing innovative ideas to improve the ability of the Network to accomplish its goals. In this application, we describe our performance as a CCC in the first five years of its existence and our general performance in site-based clinical research i cardiac surgery patients during the same time period. We also critically evaluate three Mock Trials provided in the RFA as a vehicle to demonstrate our understanding of the issues that affect successful completion of clinical trials and to propose innovations to overcome obstacles and promote that success.
It is critically important to advance the field of Cardiothoracic Surgery by using clinical research to identify and confirm the effectiveness of new surgical approaches and new technology. Of equal importance is to develop clinical research skills (Master's Level) in promising current and future Cardiothoracic Surgeons to lead the advancement effort.
|Gulack, Brian C; Mulvihill, Michael S; Ganapathi, Asvin M et al. (2018) Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study. Transpl Int 31:45-55|
|Mulvihill, Michael S; Gulack, Brian C; Ganapathi, Asvin M et al. (2017) The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation. Clin Transplant 31:|
|Castleberry, Anthony; Mulvihill, Michael S; Yerokun, Babatunde A et al. (2017) The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates. J Heart Lung Transplant 36:780-786|
|Cox, Morgan L; Yang, Chi-Fu Jeffrey; Speicher, Paul J et al. (2017) The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients. J Thorac Oncol 12:689-696|
|Osho, Asishana A; Hirji, Sameer A; Castleberry, Anthony W et al. (2017) Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. Clin Transplant 31:|
|Williams, Trevor; Gulack, Brian C; Kim, Sunghee et al. (2017) Operative Risk for Major Lung Resection Increases at Extremes of Body Mass Index. Ann Thorac Surg 103:296-302|
|Castleberry, Anthony W; Bishawi, Muath; Worni, Mathias et al. (2017) Medication Nonadherence After Lung Transplantation in Adult Recipients. Ann Thorac Surg 103:274-280|
|Anderson Jr, Kevin L; Mulvihill, Michael S; Speicher, Paul J et al. (2017) Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. Ann Thorac Surg 104:1221-1230|
|Ganapathi, Asvin M; Mulvihill, Michael S; Englum, Brian R et al. (2017) Transplant size mismatch in restrictive lung disease. Transpl Int 30:378-387|
|Hayes Jr, D; Hartwig, M G; Tobias, J D et al. (2017) Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality. Am J Transplant 17:218-226|
Showing the most recent 10 out of 166 publications